Thanks for sharing. I have no connection to Culper and went and read to the first link in its entirety. I would challenge anyone to read it and come back with a fact-based rebuttal to any of the assertions made. Sadly, they have been SPOT-ON and they use Nader's own assertions and promises.
Revenue promised years ago! debunked
BLA Approval years ago! debunked
Pestell fired for cause! debunked
Meeting and partnerships imminent! debunked
No dilution! Laughably debunked
Stock Price projections: Laughably off base
Seriously, while I love the Queen meme and the lyrics, it doesn't paint a picture of the reality.
Sub $1.41 price
No approvals
No revenue
Funding almost out if the Fife shelf isn't allowed
Shareholder lawsuits that cost MILLIONS of dollars
Arbitration loss for lying about firing Pestell
CD10 and CD12 FAILED! The 82% is a subset of a subset. Cytodyn's SEC filings say it failed! They didn't meet the endpoints. PERIOD, hard stop.
As a value investor, I'm looking for which portions of that report are not true.
Culper readily outlines it's their OPINION based on the science, trials, assertions and failures. They're totally in the clear.
Now, a CEO spewing triple-digit stock projections while selling $10+ million in stock and the CFO selling $5-6M in stock during the runup might get the SEC and DOJ's attention...oh wait! Subpoena's have been issued to a two-time felon who declared personally bankruptcy twice. Is that the moral fiber and fiscal responsibility that a mechanical engineer should possess to run a bio company?
I look forward to your response. I find them valuable.
Grip
Market Data 
Markets 
AI
